117 related articles for article (PubMed ID: 12211149)
1. DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S98-102. PubMed ID: 12211149
[No Abstract] [Full Text] [Related]
2. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
[No Abstract] [Full Text] [Related]
3. DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S93-7. PubMed ID: 12211148
[No Abstract] [Full Text] [Related]
4. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
5. DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S72-3. PubMed ID: 12211143
[No Abstract] [Full Text] [Related]
6. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
[No Abstract] [Full Text] [Related]
7. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
[No Abstract] [Full Text] [Related]
8. [Ropinirol: a new dopamine agonist in the treatment of Parkinson's disease].
Giménez-Roldán S
Neurologia; 1997 Oct; 12(8):354-61. PubMed ID: 9471165
[TBL] [Abstract][Full Text] [Related]
9. GSK's Requip slow the loss of dopamine function in Parkinson's disease.
Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117
[No Abstract] [Full Text] [Related]
10. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
11. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
[No Abstract] [Full Text] [Related]
12. Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease.
Barone P; Lamb J; Ellis A; Clarke Z
Mov Disord; 2007 Mar; 22(4):483-9. PubMed ID: 17115380
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
14. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
15. Ropinirole in the treatment of restless legs syndrome.
Kakar RS; Kushida CA
Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonists in Parkinson's disease.
Yamamoto M; Schapira AH
Expert Rev Neurother; 2008 Apr; 8(4):671-7. PubMed ID: 18416667
[TBL] [Abstract][Full Text] [Related]
17. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
Buchwald B; Angersbach D; Jost WH
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based review of dopamine receptor agonists in the treatment of Parkinson's disease.
Deleu D; Northway MG; Hanssens Y
Saudi Med J; 2002 Oct; 23(10):1165-75. PubMed ID: 12436117
[TBL] [Abstract][Full Text] [Related]
19. A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease.
Singer C; Lamb J; Ellis A; Layton G;
Mov Disord; 2007 Mar; 22(4):476-82. PubMed ID: 17318839
[TBL] [Abstract][Full Text] [Related]
20. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
